Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.

Pia PaffenholzKatharina GreinIsabel HeideggerTim NestlerMarkus GrabbertJohannes SalemMartin HellmichDavid PfisterAxel Heidenreich

Published in: World journal of urology (2018)

19% of all patients treated by platinum-based chemotherapy due to testicular cancer suffered from a venous thromboembolic event, associated with reduced overall survival. As a result, monitoring of cancer patients at risk as well as the improvement of patients' awareness of a thromboembolic event should thus be the main goal of their treating physicians.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
newly diagnosed
ejection fraction
locally advanced
primary care
pulmonary embolism
atrial fibrillation
peritoneal dialysis
squamous cell carcinoma
radiation therapy
young adults
patient reported